INFI
Infinity Pharmaceuticals, Inc.
INFI
INFI
Delisted
INFI was delisted on the 13th of September, 2023.
55 hedge funds and large institutions have $55.2M invested in Infinity Pharmaceuticals, Inc. in 2019 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 12 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
25% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 12
57% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 14
Holders
55
Holding in Top 10
1
Calls
$86K
Puts
$6K
Top Buyers
| 1 | +$199K | |
| 2 | +$177K | |
| 3 | +$106K | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$97.9K |
| 5 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
+$76K |
Top Sellers
| 1 | -$364K | |
| 2 | -$213K | |
| 3 | -$151K | |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$108K |
| 5 |
Wells Fargo
San Francisco,
California
|
-$66.7K |